Elucidating the druggability of the human proteome with eFindSite

Scikit-learn: Machine Learning in Python

Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016 · see citing works

VMD: visual molecular dynamics

Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952 · see citing works

The Protein Data Bank

Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196 · see citing works

A simple method for displaying the hydropathic character of a protein

Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,694 · see citing works

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139 · see citing works

DrugBank 5.0: a major update to the DrugBank database for 2018

Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404 · see citing works

Comparison of the predicted and observed secondary structure of T4 phage lysozyme

Matthews, B. W. (1975) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(75)90109-9 · Cited by 5,399 · see citing works

ChEMBL: a large-scale bioactivity database for drug discovery

Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · see citing works

Innovation in the pharmaceutical industry: New estimates of R&D costs

DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359 · see citing works

The druggable genome

Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305 · see citing works

ZINC 15 – Ligand Discovery for Everyone

Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224 · see citing works

A comprehensive map of molecular drug targets

Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427 · see citing works

Scoring function for automated assessment of protein structure template quality

Zhang, Y., & Skolnick, J. (2004) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20264 · Cited by 2,392 · see citing works

Discovering High-Affinity Ligands for Proteins: SAR by NMR

Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,045 · see citing works

Fpocket: An open source platform for ligand pocket detection

Guilloux, V. L., Schmidtke, P., & Tufféry, P. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-168 · Cited by 1,666 · see citing works

Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring quality of the reference assembly

Schneider, V. A., Graves-Lindsay, T., Howe, K., Bouk, N., Chen, H.-C., Kitts, P. A., Murphy, T. D., Pruitt, K. D., Thibaud-Nissen, F., Albracht, D., et al. (2017) · Genome Research · doi:10.1101/gr.213611.116 · Cited by 1,193 · see citing works

LGA: a method for finding 3D similarities in protein structures

Zemla, A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg571 · Cited by 1,069 · see citing works

Automated analysis of interatomic contacts in proteins.

Sobolev, V. M., Sorokin, A., Prilusky, J., Abola, E. E., & Edelman, M. (1999) · Bioinformatics · doi:10.1093/bioinformatics/15.4.327 · Cited by 801 · see citing works

Multinomial logistic regression algorithm

B�hning, D. (1992) · Annals of the Institute of Statistical Mathematics · doi:10.1007/bf00048682 · Cited by 557 · see citing works

Druggability Indices for Protein Targets Derived from NMR-Based Screening Data

Hajduk, P. J., Huth, J. R., & Fesik, S. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049131r · Cited by 525 · see citing works

Ensembl 2017

Aken, B. L., Achuthan, P., Akanni, W., Amode, M. R., Bernsdorff, F., Bhai, J., Billis, K., Carvalho-Silva, D., Cummins, C., Clapham, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1104 · Cited by 512 · see citing works

Open Targets: a platform for therapeutic target identification and validation

Koscielny, G., An, P., Carvalho‐Silva, D., Cham, J. A., Fumis, L., Gasparyan, R., Hasan, S., Karamanis, N., Maguire, M., Papa, E., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1055 · Cited by 500 · see citing works

Burger's Medicinal Chemistry and Drug Discovery

Abraham, D. J. (2003) · Wiley eBooks · doi:10.1002/0471266949 · Cited by 500 · see citing works

Understanding and Predicting Druggability. A High-Throughput Method for Detection of Drug Binding Sites

Schmidtke, P., & Barril, X. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100574m · Cited by 332 · see citing works

Use of Amino Acid Composition to Predict Ligand-Binding Sites

Soga, S., Shirai, H., Kobori, M., & Hirayama, N. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci6002202 · Cited by 204 · see citing works

Fragment screening to predict druggability (ligandability) and lead discovery success

Edfeldt, F., Folmer, R. H. A., & Breeze, A. L. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.002 · Cited by 201 · see citing works

sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank

Kellenberger, E., Müller, P., Schalon, C., Bret, G., Foata, N., & Rognan, D. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050372x · Cited by 198 · see citing works

Rediscovering the sweet spot in drug discovery

Brown, D., & Superti‐Furga, G. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02902-7 · Cited by 176 · see citing works

Aromatic interactions at the ligand–protein interface: Implications for the development of docking scoring functions

Bryliński, M. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13084 · Cited by 174 · see citing works

What makes a binding site a binding site?

Ringe, D. (1995) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(95)80017-4 · Cited by 125 · see citing works

PockDrug: A Model for Predicting Pocket Druggability That Overcomes Pocket Estimation Uncertainties

Borrel, A., Regad, L., Xhaard, H., Petitjean, M., & Camproux, A. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci5006004 · Cited by 118 · see citing works

DrugPred: A Structure-Based Approach To Predict Protein Druggability Developed Using an Extensive Nonredundant Data Set

Krasowski, A., Muthas, D., Sarkar, A., Schmitt, S., & Brenk, R. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200266d · Cited by 99 · see citing works

Evaluating the absolute quality of a single protein model using structural features and support vector machines

Wang, Z., Tegge, A. N., & Cheng, J. J. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22275 · Cited by 99 · see citing works

Global vision of druggability issues: applications and perspectives

Hussein, H. A., Geneix, C., Petitjean, M., Borrel, A., Flatters, D., & Camproux, A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.021 · Cited by 87 · see citing works

Build-Up Algorithm for Atomic Correspondence between Chemical Structures

Kawabata, T. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2001023 · Cited by 75 · see citing works

eFindSite: Improved prediction of ligand binding sites in protein models using meta-threading, machine learning and auxiliary ligands

Bryliński, M., & Feinstein, W. P. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9663-5 · Cited by 73 · see citing works

Successful generation of structural information for fragment-based drug discovery

Öster, L., Tapani, S., Xue, Y., & Käck, H. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.04.005 · Cited by 64 · see citing works

Structural coverage of the proteome for pharmaceutical applications

Somody, J. C., MacKinnon, S. S., & Windemuth, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.004 · Cited by 59 · see citing works

Nonlinear Scoring Functions for Similarity-Based Ligand Docking and Binding Affinity Prediction

Bryliński, M. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400510e · Cited by 50 · see citing works

Structural Insights into the Enzymatic Mechanism of Serine Palmitoyltransferase from Sphingobacterium multivorum

Ikushiro, H., Islam, M. M., Okamoto, A., Hoseki, J., Murakawa, T., Fujii, S., MIYAHARA, I., & Hayashi, H. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp100 · Cited by 49 · see citing works

The effect of deuteration on protein structure: a high-resolution comparison of hydrogenous and perdeuterated haloalkane dehalogenase

Liu, X., Hanson, B. L., Langan, P. A., & Viola, R. E. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444907037705 · Cited by 48 · see citing works

Quantitative metrics for drug–target ligandability

Vukovič, S., & Huggins, D. J. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.02.015 · Cited by 39 · see citing works

eThread: A Highly Optimized Machine Learning-Based Approach to Meta-Threading and the Modeling of Protein Tertiary Structures

Bryliński, M., & Lingam, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050200 · Cited by 36 · see citing works

eFindSite: Enhanced Fingerprint‐Based Virtual Screening Against Predicted Ligand Binding Sites in Protein Models

Feinstein, W. P., & Bryliński, M. (2014) · Molecular Informatics · doi:10.1002/minf.201300143 · Cited by 35 · see citing works

Acetobacter turbidans α-Amino Acid Ester Hydrolase

Barends, T. R. M., Polderman-Tijmes, J. J., Jekel, P. A., Williams, C., Wybenga, G. G., Janssen, D. B., & Dijkstra, B. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511187200 · Cited by 29 · see citing works

Identification and analysis of conserved pockets on protein surfaces

Cammisa, M., Correra, A., Andreotti, G., & Cubellis, M. V. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-s7-s9 · Cited by 28 · see citing works

Chemical fragment arrays for rapid druggability assessment

Aretz, J., Kondoh, Y., Honda, K., Anumala, U. R., Nazaré, M., Watanabe, N., Osada, H., & Rademacher, C. (2016) · Chemical Communications · doi:10.1039/c5cc10457b · Cited by 21 · see citing works

X-Ray snapshots of a pyridoxal enzyme: a catalytic mechanism involving concerted [1,5]-hydrogen sigmatropy in methionine γ-lyase

Sato, D., Shiba, T., Karaki, T., Yamagata, W., Nozaki, T., Nakazawa, T., & Harada, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-05032-6 · Cited by 14 · see citing works

NMR ‐Based Screening and Drug Discovery

Craik, D. J., Smith, P. A., & Clark, R. J. (2010) · Burger's Medicinal Chemistry and Drug Discovery · doi:10.1002/0471266949.bmc011.pub2 · Cited by 3 · see citing works

The art and practice of structure-based drug design: A molecular modeling perspective

(1996) · doi:10.1002/(sici)1098-1128(199601)16:1

A structural biology community assessment of AlphaFold2 applications

Akdel, M., Pires, D. E. V., Pardo, E. P., Jänes, J., Zalevsky, A. O., Mészáros, B., Bryant, P., Good, L. L., Laskowski, R. A., Pozzati, G., et al. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00849-w · Cited by 675 · see citing works

A review on machine learning approaches and trends in drug discovery

Carracedo-Reboredo, P., Liñares-Blanco, J., Rodríguez-Fernández, N., Cedrón, F., Novoa, F. J., Carballal, A., Maojo, V., Pazos, A., & Fernandez-Lozano, C. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.011 · Cited by 488 · see citing works

AI-powered therapeutic target discovery

Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.010 · Cited by 341 · see citing works

A structural biology community assessment of AlphaFold 2 applications

Akdel, M., Pires, D. E. V., Porta Pardo, E., Jänes, J., Zalevsky, A. O., Mészáros, B., Bryant, P., Good, L. L., Laskowski, R. A., Pozzati, G., et al. (2021) · doi:10.1101/2021.09.26.461876 · Cited by 122 · see citing works

Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications

Dhudum, R., Ganeshpurkar, A., & Pawar, A. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010009 · Cited by 127 · see citing works

DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets

Raies, A. B., Tulodziecka, E., Stainer, J., Middleton, L., Dhindsa, R. S., Hill, P., Engkvist, O., Harper, A. R., Petrovski, S., & Vitsios, D. (2022) · Communications Biology · doi:10.1038/s42003-022-04245-4 · Cited by 62 · see citing works

The mechanism of action and clinical value of PROTACs: A graphical review

Graham, H. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110446 · Cited by 52 · see citing works

Biophysical and Computational Approaches to Study Ternary Complexes: A ‘Cooperative Relationship’ to Rationalize Targeted Protein Degradation

Ward, J. A., Perez‐Lopez, C., & Mayor‐Ruiz, C. (2023) · ChemBioChem · doi:10.1002/cbic.202300163 · Cited by 46 · see citing works

Small-Molecule Degraders beyond PROTACs—Challenges and Opportunities

Kastl, J. M., Davies, G., Godsman, E., & Holdgate, G. A. (2021) · SLAS Discovery · doi:10.1177/2472555221991104 · Cited by 43 · see citing works

GraphSite: Ligand Binding Site Classification with Deep Graph Learning

Shi, W., Singha, M., Pu, L., Srivastava, G. N., Ramanujam, J., & Bryliński, M. (2022) · Biomolecules · doi:10.3390/biom12081053 · Cited by 29 · see citing works

Progress of AI-Driven Drug–Target Interaction Prediction and Lead Optimization

Wang, Q., Sun, B., Yi, Y., Velkov, T., Shen, J., Dai, C., & Jiang, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010037 · Cited by 32 · see citing works

AI-Based Computational Methods in Early Drug Discovery and Post Market Drug Assessment: A Survey

Rajaei, F., Minoccheri, C., Wittrup, E. M., Wilson, R. C., Athey, B. D., Omenn, G. S., & Najarian, K. (2024) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2024.3492708 · Cited by 23 · see citing works

BionoiNet: ligand-binding site classification with off-the-shelf deep neural network

Shi, W., Lemoine, J. M., Shawky, A.-E.-M., Singha, M., Pu, L., Yang, S., Ramanujam, J., & Bryliński, M. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa094 · Cited by 15 · see citing works

Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge

Xu, X., Zhang, Q., Chu, X., Quan, Y., Lv, B., & Zhang, H. (2021) · Viruses · doi:10.3390/v13112117 · Cited by 11 · see citing works

Potential Alzheimer’s disease drug targets identified through microglial biology research

Lepiarz‐Raba, I., Hidayat, T., Hannan, A. J., & Jawaid, A. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2335210 · Cited by 9 · see citing works

Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency

Iwata, H. (2024) · Bioanalysis · doi:10.1080/17576180.2024.2437283 · Cited by 9 · see citing works

Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition

Martin, H. L., Turner, A. L., Higgins, J. W., Tang, A. A.-S., Tiede, C., Taylor, T. J., Siripanthong, S., Adams, T. L., Manfield, I. W., Bell, S. M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113184 · Cited by 8 · see citing works

Transforming modern drug discovery with machine learning – applications in ligand-based drug design

Pore, S., & Roy, K. (2025) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2025.08.001 · Cited by 5 · see citing works

Utilization of AI in Designing RNA Therapeutics

Saw, P. E., & Song, E. (2025) · Springer eBooks · doi:10.1007/978-981-96-3041-7_30 · Cited by 3 · see citing works

Computational Drug Target Tractability Analysis

Leach, A. R., & Radoux, C. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11531-4 · Cited by 2 · see citing works

Graphsite: Ligand-binding site classification using Deep Graph Neural NetworkPreprint

Shi, W., Singha, M., Pu, L., Ramanujam, J., & Bryliński, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.06.471420 · Cited by 2 · see citing works

An in-silico approach for novel molecular glue design by rationalizing known molecular glue mediated ternary complex formationPreprint

S, B. G. A., Kulkarni, N. M., Agrawal, D., Bharti, N., Vetrivel, R., & Gurram, K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.04.510266 · Cited by 2 · see citing works

Affimer-Mediated Locking of a PAK5 Intermediate Activation State Reveals a Novel Mechanism of Kinase InhibitionPreprint

Martin, H. L., Turner, A. L., Higgins, J. W., Tang, A. A.-S., Tiede, C., Taylor, T. J., Adams, T. L., Bell, S. M., Morrison, E. E., Bond, J., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4350139

Novel natural nanosyringes: solving biologics delivery at the cellular level

Healey, J. R. J. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.06.003

Target identification and validation in drug discovery

Chakraborty, S., Ghosh, R., Rakshit, G., Singh, N. K., & Rudrapal, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27461-9.00005-6

Beyond Inhibition: Targeted Degradation of NLRP3 by Autophagy-Tethering Bifunctional Compounds as a Therapy for Inflammatory Bowel Disease

Zheng, X., Xue, Y., Wu, H., Liu, C., Wang, Y., Wu, K., Xie, X., 馬紹宗, Gu, X., Zhang, Z., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01995

DrugProtAI: A machine learning–driven approach for predicting protein druggability through feature engineering and robust partition-based ensemble methods

Halder, A., Samantaray, S., Barbade, S., Gupta, A., & Srivastava, S. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf330 · Cited by 9 · see citing works

DrugProtAI: A guide to the future research of investigational target proteinsPreprint

Halder, A., Samantaray, S., Barbade, S., Gupta, A., & Srivastava, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.05.622045 · Cited by 1 · see citing works

DrugPred: A Structure-Based Approach To Predict Protein Druggability Developed Using an Extensive Nonredundant Data Set

Krasowski, A., Muthas, D., Sarkar, A., Schmitt, S., & Brenk, R. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200266d · Cited by 99 · see citing works

Predicting protein druggability

Hajduk, P. J., Huth, J. R., & Tse, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03624-x · Cited by 289 · see citing works

Computational approaches to druggable site identification: Current status and future perspective

Lin, A., Zhang, Z., Jiang, A., Li, K., Shi, Y., Yang, H., Zhang, J., Liu, R., Wang, Y., Glaviano, A., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.10.032 · Cited by 9 · see citing works